Fredrik Wermeling

2.7k total citations
43 papers, 1.9k citations indexed

About

Fredrik Wermeling is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Fredrik Wermeling has authored 43 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Immunology, 13 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Fredrik Wermeling's work include Immune Cell Function and Interaction (12 papers), T-cell and B-cell Immunology (12 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Fredrik Wermeling is often cited by papers focused on Immune Cell Function and Interaction (12 papers), T-cell and B-cell Immunology (12 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Fredrik Wermeling collaborates with scholars based in Sweden, United States and Singapore. Fredrik Wermeling's co-authors include Jeffrey V. Ravetch, Robert M. Anthony, Mikael C. I. Karlsson, Toshihiko Kobayashi, Yunying Chen, Timo Pikkarainen, Karl Tryggvason, Ola Winqvist, Annika Scheynius and Susanna Cardell and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Fredrik Wermeling

42 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fredrik Wermeling Sweden 20 1.1k 686 642 168 165 43 1.9k
David A. Mancardi France 15 1.4k 1.2× 652 1.0× 1.1k 1.7× 125 0.7× 429 2.6× 19 2.2k
Marc Ehlers Germany 23 1.3k 1.2× 551 0.8× 391 0.6× 94 0.6× 68 0.4× 49 2.0k
Tchavdar L. Vassilev Bulgaria 23 840 0.7× 403 0.6× 616 1.0× 347 2.1× 69 0.4× 57 1.5k
Kenneth J. Katschke United States 22 1.3k 1.1× 506 0.7× 349 0.5× 230 1.4× 190 1.2× 28 2.3k
Andreas M. Hohlbaum United States 15 1.6k 1.4× 644 0.9× 293 0.5× 162 1.0× 57 0.3× 25 2.4k
Bruno Iannascoli France 19 1.6k 1.4× 758 1.1× 1.1k 1.7× 139 0.8× 517 3.1× 24 2.5k
Timothy R. Hercus Australia 24 1.1k 0.9× 454 0.7× 183 0.3× 205 1.2× 118 0.7× 39 1.8k
Richard D. Garman United States 24 1.3k 1.1× 403 0.6× 413 0.6× 139 0.8× 378 2.3× 34 2.2k
W.J.M. Tax Netherlands 26 1.7k 1.5× 860 1.3× 985 1.5× 220 1.3× 170 1.0× 77 2.7k
Manjula Reddy United States 23 840 0.7× 737 1.1× 208 0.3× 276 1.6× 84 0.5× 39 2.0k

Countries citing papers authored by Fredrik Wermeling

Since Specialization
Citations

This map shows the geographic impact of Fredrik Wermeling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fredrik Wermeling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fredrik Wermeling more than expected).

Fields of papers citing papers by Fredrik Wermeling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fredrik Wermeling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fredrik Wermeling. The network helps show where Fredrik Wermeling may publish in the future.

Co-authorship network of co-authors of Fredrik Wermeling

This figure shows the co-authorship network connecting the top 25 collaborators of Fredrik Wermeling. A scholar is included among the top collaborators of Fredrik Wermeling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fredrik Wermeling. Fredrik Wermeling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mo, Jiezhen, Fredrik Wermeling, Gunnar Nilsson, & Joakim S. Dahlin. (2024). CRISPR/Cas9-mediated gene disruption determines the roles of MITF and CITED2 in human mast cell differentiation. Blood Advances. 8(15). 3941–3945. 1 indexed citations
2.
Hulsart‐Billström, Gry, Bogdan Mitran, Bo Zhang, et al.. (2023). Noninvasive PET Detection of CD69-Positive Immune Cells Before Signs of Clinical Disease in Inflammatory Arthritis. Journal of Nuclear Medicine. 65(2). 294–299. 2 indexed citations
3.
Raposo, Bruno, Lena Israelsson, Heidi Wähämaa, et al.. (2023). Divergent and dominant anti-inflammatory effects of patient-derived anticitrullinated protein antibodies (ACPA) in arthritis development. Annals of the Rheumatic Diseases. 82(5). 724–726. 24 indexed citations
4.
Jiang, Long, Ming-Mei Shang, Fredrik Wermeling, et al.. (2023). High‐content screening of drug combinations of an mPGES ‐1 inhibitor in multicellular tumor spheroids leads to mechanistic insights into neuroblastoma chemoresistance. Molecular Oncology. 18(2). 317–335. 5 indexed citations
5.
Spiegelberg, Diana, Pavitra Kannan, Long Jiang, et al.. (2022). The MDM2 Inhibitor Navtemadlin Arrests Mouse Melanoma Growth In Vivo and Potentiates Radiotherapy. Cancer Research Communications. 2(9). 1075–1088. 8 indexed citations
6.
Johnsson, Anna‐Karin, Bruno Raposo, Ravi Sharma, et al.. (2022). Modulating T-cell activation with antisense oligonucleotides targeting lymphocyte cytosolic protein 2. Journal of Autoimmunity. 131. 102857–102857. 9 indexed citations
7.
Kumar, Suresh, Andreas Schneider, Fredrik Wermeling, et al.. (2021). In Vivo Lentiviral Gene Delivery of HLA-DR and Vaccination of Humanized Mice for Improving the Human T and B Cell Immune Reconstitution. Biomedicines. 9(8). 961–961. 4 indexed citations
8.
Sharma, Ravi, Anatoly Dubnovitsky, Bruno Raposo, et al.. (2021). In vitro and ex vivo functional characterization of human HLA-DRB1∗04 restricted T cell receptors. Journal of Translational Autoimmunity. 4. 100087–100087. 7 indexed citations
9.
Jiang, Long, et al.. (2021). A rapid CRISPR competitive assay for in vitro and in vivo discovery of potential drug targets affecting the hematopoietic system. Computational and Structural Biotechnology Journal. 19. 5360–5370. 2 indexed citations
10.
Sharma, Ravi, Niyaz Yoosuf, Anatoly Dubnovitsky, et al.. (2021). Biased TCR gene usage in citrullinated Tenascin C specific T-cells in rheumatoid arthritis. Scientific Reports. 11(1). 24512–24512. 20 indexed citations
11.
Jiang, Long, et al.. (2020). Designing custom CRISPR libraries for hypothesis-driven drug target discovery. Computational and Structural Biotechnology Journal. 18. 2237–2246. 12 indexed citations
12.
Panda, Sudeepta Kumar, Gustaf Wigerblad, Long Jiang, et al.. (2020). IL-4 controls activated neutrophil FcγR2b expression and migration into inflamed joints. Proceedings of the National Academy of Sciences. 117(6). 3103–3113. 27 indexed citations
13.
Xu, Xingxing, Asta Makaraviciute, Eldar Abdurakhmanov, et al.. (2019). Estimating Detection Limits of Potentiometric DNA Sensors Using Surface Plasmon Resonance Analyses. ACS Sensors. 5(1). 217–224. 13 indexed citations
14.
Aeinehband, Shahin, et al.. (2017). A Role for the Transcription Factor Arid3a in Mouse B2 Lymphocyte Expansion and Peritoneal B1a Generation. Frontiers in Immunology. 8. 1387–1387. 8 indexed citations
15.
Duhlin, Amanda, Yunying Chen, Fredrik Wermeling, et al.. (2016). Selective Memory to Apoptotic Cell–Derived Self-Antigens with Implications for Systemic Lupus Erythematosus Development. The Journal of Immunology. 197(7). 2618–2626. 13 indexed citations
16.
Georgoudaki, Anna‐Maria, Silke Sohn, Fredrik Wermeling, et al.. (2016). Cutting Edge: Marginal Zone Macrophages Regulate Antigen Transport by B Cells to the Follicle in the Spleen via CD21. The Journal of Immunology. 197(6). 2063–2068. 20 indexed citations
17.
Ulrich, Martina, Fredrik Wermeling, Tilo Biedermann, et al.. (2014). Invariant Natural Killer T (iNKT) Cells Prevent Autoimmunity, but Induce Pulmonary Inflammation in Cystic Fibrosis. Cellular Physiology and Biochemistry. 34(1). 56–70. 25 indexed citations
18.
Wermeling, Fredrik, et al.. (2010). Invariant NKT cells limit activation of autoreactive CD1d-positive B cells. The Journal of Experimental Medicine. 207(5). 943–952. 72 indexed citations
19.
Chen, Yunying, Fredrik Wermeling, Ann‐Beth Jonsson, et al.. (2010). A regulatory role for macrophage class A scavenger receptors in TLR4‐mediated LPS responses. European Journal of Immunology. 40(5). 1451–1460. 47 indexed citations
20.
Thunberg, Sarah, Theresa Neimert-Andersson, Qing Cheng, et al.. (2009). Prolonged antigen‐exposure with carbohydrate particle based vaccination prevents allergic immune responses in sensitized mice. Allergy. 64(6). 919–926. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David A. Mancardi Breakdown of academic impact, for papers by Marc Ehlers Breakdown of academic impact, for papers by Tchavdar L. Vassilev Breakdown of academic impact, for papers by Kenneth J. Katschke Breakdown of academic impact, for papers by Andreas M. Hohlbaum Breakdown of academic impact, for papers by Bruno Iannascoli Breakdown of academic impact, for papers by Timothy R. Hercus Breakdown of academic impact, for papers by Richard D. Garman Breakdown of academic impact, for papers by W.J.M. Tax Breakdown of academic impact, for papers by Manjula Reddy
Rankless by CCL
2026